Country Trust Bank’s Maravai LifeSciences MRVI Stock Holding History

Country Trust Bank’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-651	Closed	-$5.41K	–	390
2024 Q3	$5.41K	Buy	+651	New	+$5.63K	﹤0.01%	279

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Country Trust Bank's MRVI Position: Q4 2024 in Review

Country Trust Bank sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 651 shares — an estimated $5.41K sold.

Country Trust Bank first reported a position in MRVI in Q3 2024 and held it in 1 quarter. The position peaked at $5.41K in Q3 2024. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

Country Trust Bank reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
Country Trust Bank sold 651 Maravai LifeSciences shares in Q4 2024, an estimated $5.41K.
Country Trust Bank first reported a position in Maravai LifeSciences in Q3 2024 and held it in 1 quarter.
Country Trust Bank's Maravai LifeSciences position peaked at $5.41K in Q3 2024.
185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on Country Trust Bank's 13F filing for Q4 2024, filed 23 Jan 2025.